Colorectal cancer in African Americans

Reviews in Gastroenterological Disorders

Volumn 4, Issue 2, 2004, Pages 60-65

  Rex, Douglas K ^a   Rawl, Susan M ^a   Rabeneck, Linda ^b   Rex, Emilie K ^a   Hamilton, Frank ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Colorectal cancer; Epidemiology; Ethnicity; Prevention; Race; Screening; Survival

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AWARENESS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; MALE; MASS SCREENING; MEDICAL SPECIALIST; MEDICARE; RACE DIFFERENCE; REVIEW; SURVIVAL RATE; UNITED STATES; AGED; CANCER STAGING; COLORECTAL TUMOR; INCIDENCE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; STATISTICS; SURVIVAL;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; UNITED STATES;

EID: 2942689926     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003. Available at: http://seer.cancer.gov/csr/.
3. Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52:326-341.
4. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the US: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer. 1999;85:1670-1676.
5. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-856.
6. Parker SL, Davis KJ, Wingo PA, et al. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31-48.
7. Clegg LX, Li FP, Hankey BE, et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population based study. Arch Intern Med. 2002;162:1985-1993.
8. Wingo PA, Ries LAG, Parker SL, Heath CW. Long term survival in the United States. Cancer Epidemiol Biomarkers Prep. 1998;7:271-282.
9. Merrill RM, Henson DE, Ries LAG. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998;41:1097-1106.
10. Mayberry RM, Coates RJ, Hill HA, Click LA. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686-1693.
11. Marcella S, Miller JE. Racial differences in colorectal cancer mortality: the importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359-366.
12. Mandelblatt J, Andrews H, Kao R, et al. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996;86:1794-1797.
13. Wudel LJ, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer. Effect of race on long-term survival. Arch Surg. 2002;137:550-556.
14. Freeman HP, Alshafie TA. Colorectal carcinoma in poor blacks. Cancer. 2002;94:2327-2332.
15. Baquet CR, Commiskey P. Colorectal cancer epidemiology in minorities: a review. J Assoc Acad Minor Phys. 1999;10:51-58.
16. Hargreaves MK, Baquet C, Gamshadzahi A. Diet, nutritional status and cancer risk in American blacks. Nutr Cancer. 1989;12:1-28.
17. Santini DL, Rigas B, Shift SJ. Role of diet and NSAIDs in the chemoprevention of colorectal cancer. J Assoc Acad Minor Phys. 1999;10:68-74.
18. Butler LM, Sinha R, Millikan RC, et al. Heterocyclic amines, meat intake, and association with colon cancer in a population based study. Am J Epidemiol. 2003;157:434-445.
19. Coughlin SS, Thompson TD, Seeff L, et al. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S. Cancer. 2002;95:2211-2222.
20. Hoffman-Goetz L, Breen NL, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis. 1998;8:43-51.
21. Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991;81:501-504.
22. O'Malley AS, Forrest CB, Mandelblatt J. Adherence of low-income women to cancer screening recommendations. The roles of primary care, health insurance, and HMOs. J Gen Intern Med. 2002;17:144-154.
23. Ioannou GN. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98:2082-2091.
24. Richards RJ, Reker DM. Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries. Dig Dis Sci. 2002;47:2715-2719.
25. McMahon LF, Wolfe RA, Huang S, et al. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care. 1999;57:712-717.
26. Roetzheim RG, Pal N, Gonzalez EC, et al. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000;90:1746-1754.
27. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
28. Cooper GS, Yuan Z, Landefeld CS, Rimm AA. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health. 1996;86:582-586.
29. Potosky AL, Harlan LC, Kaplan RS, et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192-1202.
30. Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003;97:493-498.
31. Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998;82:2312-2320.
32. Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the VA health care system. Am J Gastroenterol. 2003;98:1186-1192.
33. McCollum AD, Catalano PJ, Haller DG, et al. Outcomes and toxicity in African Americans and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002;94:1160-1167.
34. Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the national surgical adjuvant breast and bowel project. J Natl Cancer Inst. 1999;91:1933-1940.
35. Ionesco MV, Carey F, Tait IS, Steele RJC. Socioeconomic status and stage at presentation of colorectal cancer. Lancet. 1986;58:1439.
36. Robinson SB, Ashley M, Haynes MA. Attitudes of African Americans regarding screening for prostate cancer. J Natl Med Assoc. 1996; 88:241-246.
37. Powe BD, Weinrich S. An intervention to decrease cancer fatalism among rural elders. Oncol Nurs Forum. 1999;26:583-588.
38. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: How does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev. 2002;11:529-534.
39. Powe BD. Fatalism among elderly African Americans: effects on colorectal cancer screening. CancerNurs. 1995;18:385-392.
40. Powe BD. Cancer fatalism among African Americans: a review of the literature. Nurs Outlook. 1996;44:18-21.
41. Powe BD. Perceptions of cancer fatalism among African Americans: the influence of education, income, and cancer knowledge. J Natl Black Nurs Assoc. 1994;7:41-48.
42. van Ryn M, Burke J. The effect of patient race and socio-economic status on physician perceptions of patients. Soc Sci Med. 2000;50:813-828.
43. Carethers JM. Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys. 1999;10:59-67.
44. Theuer CP, Taylor TH, Brewster WR, et al. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg. 2001;67:1157-1161.
45. Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med. 2000;31:447-453.
46. Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum. 2001;44:251-257.
47. Nelson RL, Persky V, Turyk M. Carcinoma in situ of the colorectum: SEER trends by race, gender, and total colorectal cancer. J Surg Oncol. 1999;71:123-129.
48. Chattar-Cora D, Onime GD, Valentine IS, et al. Colorectal cancer in a multi-ethnic urban group: its anatomical and age profile. Int Surg. 2000;85:137-142.
49. Demers RY, Severson RK, Schottenfeld D, Lazar L. Incidence of colorectal adenocarcinoma by anatomic subsite: an epidemiologic study of time trends and racial differences in the Detroit, MI area. Cancer. 1997;79:441-447.
50. Sharma VK, Vasudeva R, Howden CW. Changes in colorectal cancer over a 15-year period in a single United States city. Am J Gastroenterol. 2000;95:3615-3619.
51. Johnson H, Carstens R. Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population. Cancer. 1986;58:997-1000.
52. Thomas CR, Jarosz R, Evans N. Racial differences in the anatomical distribution of colon cancer. Colon Cancer. 1992;127:1241-1245.
53. Chu KC, Tarone RE, Chow WH, Alexander GA. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med. 1995;4:849-856.
54. Wu XC, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer. 2001; 92:2547-2554.
55. Devesa SS, Chow WH. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer. 1993;71:3819-3826.
56. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003; 98:1400-1409.
57. Rex DK, Khan AM, Shah P, et al. Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc. 2000; 51:524-527.
58. Ozick LA, Jacob L, Donelson SS, et al. Distribution of adenomatous polyps in African Americans. Am J Gastroenterol. 1995;90:758-760.
59. Johnson H, Margolis I, Wise L. Site-specific distribution of large-bowel adenomatous polyps. Emphasis on ethnic differences. Dis Colon Rectum. 1988;31:258-260.
60. Offerhaus GJA, Giardiello FM, Tersmette KWF, et al. Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer. 1991;49:641-644.
61. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the National Health Interview Survey. Cancer. 2003;97:1528-1540.
62. Breen N, Wagener DK, Brown ML, et al. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93:1704-1713.
63. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests: results from the 1992 National Health Interview Survey. Med Care. 1998;36:257-270.
64. Proctor BD, Dalaker J. Poverty in the United States: 2002. U.S. Census Bureau, Current Population Reports; Washington, DC: U.S. Government Printing Office; 2003; P60-222.
65. Legler J, Meissner HI, Coyne C, et al. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev. 2002;11:59-71.
66. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a parricipant-friendly system. J Natl Cancer Inst. 1995;87:1747-1759.
67. Paskett ED, DeGraffinreid C, Tatum CM, Margitic SE. The recruitment of African Americans to cancer prevention and control studies. Prev Med. 1996;25:547-553.
68. Stallings FL, Ford ME, Simpson NK, et al. Black participation in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000;21:379S-389S.